These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 9552308)
41. Evaluation of nebulizers for use in neonatal ventilator circuits. Cameron D; Clay M; Silverman M Crit Care Med; 1990 Aug; 18(8):866-70. PubMed ID: 2379401 [TBL] [Abstract][Full Text] [Related]
42. Study of nebulization delivery of aerosolized fluorescent microspheres to the avian respiratory tract. Tell LA; Stephens K; Teague SV; Pinkerton KE; Raabe OG Avian Dis; 2012 Jun; 56(2):381-6. PubMed ID: 22856198 [TBL] [Abstract][Full Text] [Related]
43. Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features. Dailey LA; Schmehl T; Gessler T; Wittmar M; Grimminger F; Seeger W; Kissel T J Control Release; 2003 Jan; 86(1):131-44. PubMed ID: 12490379 [TBL] [Abstract][Full Text] [Related]
44. Characterization of nebulized buparvaquone nanosuspensions--effect of nebulization technology. Hernández-Trejo N; Kayser O; Steckel H; Müller RH J Drug Target; 2005; 13(8-9):499-507. PubMed ID: 16332575 [TBL] [Abstract][Full Text] [Related]
45. Nebulizer performance: AFLM study. Association Française de Lutte contre la Mucoviscidose. Faurisson F; Dessanges JF; Grimfeld A; Beaulieu R; Kitzis MD; Peytavin G; Lefebvre JP; Farinotti R; Sautegeau A Respiration; 1995; 62 Suppl 1():13-8. PubMed ID: 7792434 [TBL] [Abstract][Full Text] [Related]
46. A study of the effects of sodium halides on the performance of air-jet and vibrating-mesh nebulizers. Najlah M; Vali A; Taylor M; Arafat BT; Ahmed W; Phoenix DA; Taylor KM; Elhissi A Int J Pharm; 2013 Nov; 456(2):520-7. PubMed ID: 23973409 [TBL] [Abstract][Full Text] [Related]
47. Perfluorocarbon species and nebulizer type influence aerosolization rate and particle size of perfluorocarbon aerosol. Rüdiger M; Gregor T; Burkhardt W; Proquitté H; Wauer RR; Schmalisch G J Crit Care; 2004 Mar; 19(1):42-7. PubMed ID: 15101005 [TBL] [Abstract][Full Text] [Related]
48. Lung deposition in cystic fibrosis patients using an ultrasonic or a jet nebulizer. Köhler E; Sollich V; Schuster-Wonka R; Hühnerbein J J Aerosol Med; 2003; 16(1):37-46. PubMed ID: 12737683 [TBL] [Abstract][Full Text] [Related]
49. Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers. McCallion ON; Taylor KM; Thomas M; Taylor AJ Pharm Res; 1995 Nov; 12(11):1682-8. PubMed ID: 8592670 [TBL] [Abstract][Full Text] [Related]
50. Further experimentation of inhaled; LANTUS, ACTRAPID and HUMULIN with todays' production systems. Zarogoulidis P; Petridis D; Ritzoulis C; Li Q; Huang H; Ning Y; Darwiche K; Freitag L; Zarogoulidis K Int J Pharm; 2013 Dec; 458(1):39-47. PubMed ID: 24140545 [TBL] [Abstract][Full Text] [Related]
51. Novel Use of Vitamin B2 as a Fluorescent Tracer in Aerosol and Droplet Contamination Models in Otolaryngology. Sim ES; Dharmarajan H; Boorgu DSSK; Goyal L; Weinstock M; Whelan R; Freiser ME; Corcoran TE; Jabbour N; Wang E; Chi DH Ann Otol Rhinol Laryngol; 2021 Mar; 130(3):280-285. PubMed ID: 32795090 [TBL] [Abstract][Full Text] [Related]
52. Properties of aerosols produced with three nebulizers. Ferron GA; Kerrebijn KF; Weber J Am Rev Respir Dis; 1976 Nov; 114(5):899-908. PubMed ID: 984582 [TBL] [Abstract][Full Text] [Related]
53. Characterization of nebulized liposomal amikacin (Arikace) as a function of droplet size. Li Z; Zhang Y; Wurtz W; Lee JK; Malinin VS; Durwas-Krishnan S; Meers P; Perkins WR J Aerosol Med Pulm Drug Deliv; 2008 Sep; 21(3):245-54. PubMed ID: 18759656 [TBL] [Abstract][Full Text] [Related]
54. Exhaled air and aerosolized droplet dispersion during application of a jet nebulizer. Hui DS; Chow BK; Chu LCY; Ng SS; Hall SD; Gin T; Chan MTV Chest; 2009 Mar; 135(3):648-654. PubMed ID: 19265085 [TBL] [Abstract][Full Text] [Related]
55. Aerosolization potential of cyclodextrins--influence of the operating conditions. Le VN; Leterme P; Gayot A; Flament MP PDA J Pharm Sci Technol; 2006; 60(5):314-22. PubMed ID: 17089700 [TBL] [Abstract][Full Text] [Related]
56. Ultrasonic nebulization of cationic lipid-based gene delivery systems for airway administration. Pillai R; Petrak K; Blezinger P; Deshpande D; Florack V; Freimark B; Padmabandu G; Rolland A Pharm Res; 1998 Nov; 15(11):1743-7. PubMed ID: 9833997 [TBL] [Abstract][Full Text] [Related]
57. Selective deposition of inhaled aerosols to mechanically ventilated rabbits. Dahlbäck M; Wollmer P; Jonson B J Aerosol Med; 1994; 7(4):315-24. PubMed ID: 10150485 [TBL] [Abstract][Full Text] [Related]
58. Deposition of differently sized airborne microspheres in the respiratory tract of chickens. Corbanie EA; Matthijs MG; van Eck JH; Remon JP; Landman WJ; Vervaet C Avian Pathol; 2006 Dec; 35(6):475-85. PubMed ID: 17121737 [TBL] [Abstract][Full Text] [Related]
59. Stability of recombinant consensus interferon to air-jet and ultrasonic nebulization. Ip AY; Arakawa T; Silvers H; Ransone CM; Niven RW J Pharm Sci; 1995 Oct; 84(10):1210-4. PubMed ID: 8801336 [TBL] [Abstract][Full Text] [Related]
60. Why do medical nebulizers differ in their output and particle size characteristics? Nerbrink O; Dahlbäck M; Hansson HC J Aerosol Med; 1994; 7(3):259-76. PubMed ID: 10150483 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]